Evidence map›Paper›PMID 25932204›Full record

ArticleInternational journal of clinical and experimental medicine2015

The effect of silymarin on hepatic regeneration after partial hepatectomy: is silymarin effective in hepatic regeneration?

Suleyman Cetinkunar, Serhat Tokgoz, Bulent Caglar Bilgin, Hasan Erdem, Recep Aktimur, Serpil Can, Huseyin Serkan Erol, Atilla Isgoren, Selim Sozen, Yilmaz Polat

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Influence of Milk Thistle (Animals : an open access journal from MDPI · 2021
    Article
  5. Review
  6. May dexpanthenol, platelet-rich plasma, and thymoquinone provide new hope to maintain liver regeneration after partial hepatectomy?The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2019
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Suleyman CetinkunarAdana Numune Egitim ve Arastirma Hastanesi, Genel Cerrahi Klinigi Adana, Türkiye.
Serhat TokgozAnkara Diskapi Yildirim Beyazit Egitim ve Arastirma Hastanesi, Genel Cerrahi Klinigi Ankara, Türkiye.
Bulent Caglar BilginKafkas Universitesi Tip Fakultesi, Genel Cerrahi Ana Bilim Dali Kars, Türkiye.
Hasan ErdemAdana Numune Egitim ve Arastirma Hastanesi, Genel Cerrahi Klinigi Adana, Türkiye.
Recep AktimurSamsun Egitim ve Arastirma Hastanesi, Genel Cerrahi Klinigi Samsun, Türkiye.
Serpil CanKafkas Universitesi Tip Fakultesi, Fizyoloji Ana Bilim Dali Kars, Türkiye.
Huseyin Serkan ErolAtaturk Universitesi Veterinerlik Fakultesi, Biyokimya Ana Bilim Dali Erzurum, Türkiye.
Atilla IsgorenAnkara Universtesi, Veterinerlik Fakultesi Ankara, Türkiye.
Selim SozenNamik Kemal Universitesi Tip Fakultesi, Genel Cerrahi Ana Bilim Dali Tekirdag, Türkiye.
Yilmaz PolatMedikal Park Hastanesi, Genel Cerrahi Klinigi Elazig, Turkiye.
Adana Numune Eğitim ve Araştırma Hastanesi · TRKafkas University · TRAnkara University · TRAtatürk University · TRDışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi · TRDr Sami Ulus Çocuk Sağlığı ve Hastalıkları Eğitim ve Araştırma Hastanesi · TRErgani Devlet Hastanesi · TRTekirdağ Namık Kemal University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimSilymarin from Silybum marianum was found to reduce liver injury. The aim of the present study was to investigate the effects of silymarin on hepatic regeneration in partially hepatectomized rats.

methodsThirty Wistar-Albino rats were divided into 3 groups of 10 animals as sham, control and experimental groups. In the sham group (n=10) abdominal incision was closed after laparotomy. In the control group (n=10), the rats underwent 70% hepatectomy after laparotomy. In the experimental group (n=10) after partial 70% hepatectomy, silymarin (200 mg/kg/d) were given to rats for 10 days. Rats in three groups were sacrificed on 10 days. Aspartate (AST) and alanine transaminase (ALT), gamma glutamyl transferase (GGT), ALP, LDH and total bilirubin levels were measured using intracardiac blood samples. Tissue malondialdehyde (MDA) and tissue glutathion (GSH) and Superoxide dismutase (SOD) levels were measured. To reveal the increase in the mass of the remnant liver tissue in the control and experimental groups relative weight of the liver was calculated. Histopathological analysis of the liver was performed using a semi-quantitative scoring system.

resultsA statistically significant difference among three groups was not shown for AST and ALT levels. A statistically significant difference was found between the groups as for total bilirubin and gamma glutamyl transferase levels. Increases in relative liver weights were seen with time in Groups 2 and 3. A statistically significant difference was not found for tissue malondialdehyde, Glutathion and Superoxide dismutase levels between hepatectomy and hepatectomy + silymarin groups. On liver tissue sections of the rats in the hepatectomy + silymarin group, increased regeneration and lipid peroxidation were observed accompanied by decreased antioxidant response.

conclusionIt has been observed that silymarin with many established functions such as antiproliferative, anti-inflammatory and energy antioxidant effects, does not contributed to proliferative regeneration of the liver-which has very important metabolic functions -after partial hepatectomy; instead it will decrease serum levels of transaminases.

Indexed as

hepatectomyhepatic regenerationSilymarin

Identifiers

PMID25932204
PMCPMC4402851
OpenAlexW354055396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.